Moderna R&D: Rumblings or Just the Usual Biotech Buzz?

Hey all, been at Moderna for a few years now, primarily in R&D. Lately, there's been a lot of talk swirling around, especially with some of the recent industry news about funding shifts and other companies making cuts. I've seen some chatter on Mastodon and other places mentioning potential layoffs or major project re-alignments. Personally, things feel... a bit tense? We're hearing a lot about strategic prioritization and focusing on the pipeline, which is standard, but the *tone* feels different. Some teams seem a bit leaner, and there's a general sense of 'are we next?' I haven't seen any official announcements or even credible leaks about specific numbers, but the undercurrent is definitely there. Anyone else in R&D or adjacent roles feeling this vibe? Are you hearing anything more concrete, or is this just the usual biotech anxiety amplified by the current climate?